GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Ypsomed Holding AG (CHIX:YPSNz) » Definitions » Gross Profit

Ypsomed Holding AG (CHIX:YPSNZ) Gross Profit : CHF189.1 Mil (TTM As of Mar. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Ypsomed Holding AG Gross Profit?

Ypsomed Holding AG's gross profit for the six months ended in Mar. 2024 was CHF101.2 Mil. Ypsomed Holding AG's gross profit for the trailing twelve months (TTM) ended in Mar. 2024 was CHF189.1 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Ypsomed Holding AG's gross profit for the six months ended in Mar. 2024 was CHF101.2 Mil. Ypsomed Holding AG's Revenue for the six months ended in Mar. 2024 was CHF293.1 Mil. Therefore, Ypsomed Holding AG's Gross Margin % for the quarter that ended in Mar. 2024 was 34.54%.

Ypsomed Holding AG had a gross margin of 34.54% for the quarter that ended in Mar. 2024 => Competition eroding margins

During the past 13 years, the highest Gross Margin % of Ypsomed Holding AG was 34.47%. The lowest was 23.07%. And the median was 29.13%.


Ypsomed Holding AG Gross Profit Historical Data

The historical data trend for Ypsomed Holding AG's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ypsomed Holding AG Gross Profit Chart

Ypsomed Holding AG Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 90.97 94.83 113.82 140.59 189.05

Ypsomed Holding AG Semi-Annual Data
Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 61.48 65.45 75.14 87.82 101.24

Competitive Comparison of Ypsomed Holding AG's Gross Profit

For the Medical Instruments & Supplies subindustry, Ypsomed Holding AG's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ypsomed Holding AG's Gross Profit Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ypsomed Holding AG's Gross Profit distribution charts can be found below:

* The bar in red indicates where Ypsomed Holding AG's Gross Profit falls into.



Ypsomed Holding AG Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Ypsomed Holding AG's Gross Profit for the fiscal year that ended in Mar. 2024 is calculated as

Gross Profit (A: Mar. 2024 )=Revenue - Cost of Goods Sold
=548.457 - 359.404
=189.1

Ypsomed Holding AG's Gross Profit for the quarter that ended in Mar. 2024 is calculated as

Gross Profit (Q: Mar. 2024 )=Revenue - Cost of Goods Sold
=293.067 - 191.831
=101.2

Gross Profit for the trailing twelve months (TTM) ended in Mar. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF189.1 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Ypsomed Holding AG's Gross Margin % for the quarter that ended in Mar. 2024 is calculated as

Gross Margin % (Q: Mar. 2024 )=Gross Profit (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=101.2 / 293.067
=34.54 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Ypsomed Holding AG  (CHIX:YPSNz) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Ypsomed Holding AG had a gross margin of 34.54% for the quarter that ended in Mar. 2024 => Competition eroding margins


Ypsomed Holding AG Gross Profit Related Terms

Thank you for viewing the detailed overview of Ypsomed Holding AG's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Ypsomed Holding AG Business Description

Traded in Other Exchanges
Address
Brunnmattstrasse 6, Burgdorf, CHE, 3401
Ypsomed Holding AG is a Swiss company that develops and manufactures injection and infusion systems that allow patients to self-administer medication. Specifically, the company focuses on ensuring the ease of diabetes and insulin injection. The company offers various products such as pen needles with a unique click-on function. The company operates under two reportable segments: diabetes care and delivery systems goods and services. Diabetes care and delivery systems goods and services.

Ypsomed Holding AG Headlines

No Headlines